IRF6 and transient ischemic attack: To test further this hypothesis in vivo, we constructed an in vivo murine model of transient cerebral ischemia via MCA occlusion in WT and IRF6 knockdown mice and assessed pioglitazone’s effects upon miR-106a expression 24 hours post-MCA occlusion.